Free Trial

Aeterna Zentaris (AEZS) Competitors

Aeterna Zentaris logo
$3.68 +0.11 (+3.08%)
As of 06/16/2025

AEZS vs. CALC, CMMB, NRSN, NNVC, CARA, TENX, XFOR, CYTH, OVID, and IMNN

Should you be buying Aeterna Zentaris stock or one of its competitors? The main competitors of Aeterna Zentaris include CalciMedica (CALC), Chemomab Therapeutics (CMMB), NeuroSense Therapeutics (NRSN), NanoViricides (NNVC), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), X4 Pharmaceuticals (XFOR), Cyclo Therapeutics (CYTH), Ovid Therapeutics (OVID), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry.

Aeterna Zentaris vs. Its Competitors

Aeterna Zentaris (NASDAQ:AEZS) and CalciMedica (NASDAQ:CALC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Aeterna Zentaris has higher revenue and earnings than CalciMedica. CalciMedica is trading at a lower price-to-earnings ratio than Aeterna Zentaris, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aeterna Zentaris$2.37M2.78-$16.55M-$14.86-0.25
CalciMedicaN/AN/A-$34.36M-$1.56-1.11

Aeterna Zentaris has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, CalciMedica has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

CalciMedica has a net margin of 0.00% compared to Aeterna Zentaris' net margin of -760.32%. Aeterna Zentaris' return on equity of -83.45% beat CalciMedica's return on equity.

Company Net Margins Return on Equity Return on Assets
Aeterna Zentaris-760.32% -83.45% -45.76%
CalciMedica N/A -164.24%-103.53%

In the previous week, CalciMedica had 4 more articles in the media than Aeterna Zentaris. MarketBeat recorded 4 mentions for CalciMedica and 0 mentions for Aeterna Zentaris. CalciMedica's average media sentiment score of 0.72 beat Aeterna Zentaris' score of 0.00 indicating that CalciMedica is being referred to more favorably in the news media.

Company Overall Sentiment
Aeterna Zentaris Neutral
CalciMedica Positive

CalciMedica has a consensus target price of $18.00, suggesting a potential upside of 943.48%. Given CalciMedica's stronger consensus rating and higher probable upside, analysts plainly believe CalciMedica is more favorable than Aeterna Zentaris.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aeterna Zentaris
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CalciMedica
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Aeterna Zentaris received 401 more outperform votes than CalciMedica when rated by MarketBeat users. However, 94.74% of users gave CalciMedica an outperform vote while only 58.28% of users gave Aeterna Zentaris an outperform vote.

CompanyUnderperformOutperform
Aeterna ZentarisOutperform Votes
419
58.28%
Underperform Votes
300
41.72%
CalciMedicaOutperform Votes
18
94.74%
Underperform Votes
1
5.26%

0.7% of Aeterna Zentaris shares are held by institutional investors. 0.1% of Aeterna Zentaris shares are held by company insiders. Comparatively, 41.5% of CalciMedica shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

CalciMedica beats Aeterna Zentaris on 9 of the 17 factors compared between the two stocks.

Get Aeterna Zentaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEZS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEZS vs. The Competition

MetricAeterna ZentarisPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$6.60M$6.70B$5.47B$8.59B
Dividend YieldN/A2.46%5.27%4.17%
P/E Ratio-0.258.5126.5519.76
Price / Sales2.78259.84400.67151.21
Price / CashN/A65.8538.2534.64
Price / Book0.256.527.274.65
Net Income-$16.55M$143.21M$3.22B$247.89M
7 Day Performance1.94%-1.71%-2.41%-1.62%
1 Month Performance2.22%8.65%5.02%2.66%
1 Year Performance-37.73%4.30%35.95%15.48%

Aeterna Zentaris Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEZS
Aeterna Zentaris
N/A$3.68
+3.1%
N/A-44.6%$6.60M$2.37M-0.2520Gap Up
CALC
CalciMedica
3.2298 of 5 stars
$1.79
+2.9%
$18.00
+905.6%
-65.2%$25.01MN/A-1.6630Gap Up
CMMB
Chemomab Therapeutics
3.5471 of 5 stars
$1.32
-0.1%
$8.50
+543.9%
+8.8%$24.92MN/A-1.3220
NRSN
NeuroSense Therapeutics
2.357 of 5 stars
$1.90
+6.1%
$14.00
+636.8%
+152.6%$24.46MN/A-2.9710News Coverage
Upcoming Earnings
Gap Up
NNVC
NanoViricides
0.0797 of 5 stars
$1.52
-1.3%
N/A-23.7%$24.43MN/A-2.1120Short Interest ↑
CARA
Cara Therapeutics
0.2779 of 5 stars
N/A$36.00
+∞
N/A$24.33M$7.14M-0.2580Gap Down
High Trading Volume
TENX
Tenax Therapeutics
1.6551 of 5 stars
$5.86
-3.3%
$17.50
+198.6%
+94.6%$24.31MN/A-2.369Positive News
Gap Down
XFOR
X4 Pharmaceuticals
4.3467 of 5 stars
$4.14
-3.7%
$72.33
+1,647.2%
-91.1%$23.97M$31.36M-45.9980News Coverage
Short Interest ↑
CYTH
Cyclo Therapeutics
N/A$0.72
flat
$0.95
+31.8%
N/A$23.72M$870.73K-0.809
OVID
Ovid Therapeutics
4.3983 of 5 stars
$0.33
+4.0%
$2.78
+740.4%
-91.2%$23.55M$548K-0.7060Gap Up
High Trading Volume
IMNN
Imunon
2.3114 of 5 stars
$1.33
-8.9%
$15.50
+1,065.4%
+1.8%$23.33M$500K-0.7030

Related Companies and Tools


This page (NASDAQ:AEZS) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners